Cefotiam Hydrochloride

盐酸头孢替安

Report date: 2022/08/22 14:08:47
NME

Base Information

Drug NameCefotiam Hydrochloride
Drug Alias NameCefotiamum头孢替安盐酸盐头孢替安HalosporPansporin +[8] 
ClassificationSmall molecules > Heterocyclic drugs > AntibioticsSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsUrinary Tract InfectionsRespiratory Tract InfectionsBacterial Infections +[4] 
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryN/A
Original Approved Date1980/01/01
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co LtdBeijing Boshi Antai Technology Development Co Ltd
Inactive CompaniesN/A
Active IndicationsUrinary Tract InfectionsRespiratory Tract InfectionsBacterial Infections
Inactive IndicationsInfections

Other Information

ATC CodeJ01DC07
Related LinksWikipediaDrugBankKEGG